Conditions:  Metastatic Colorectal Adenocarcinoma;  Metastatic Pancreatic Ductal Adenocarcinoma;  Stage IV Colorectal Cancer AJCC v7;  Stage IV Pancreatic Cancer AJCC v6 and v7;  Stage IVA Colorectal Cancer AJCC v7;  Stage IVB Colorectal Cancer AJCC v7
Interventions: Â Drug:Â Imiquimod; Â Biological:Â Pembrolizumab; Â Biological:Â Sotigalimab; Â Biological: Synthetic Tumor-Associated Peptide Vaccine Therapy
Sponsors:  M.D. Anderson Cancer Center;  National Cancer Institute (NCI)
**RECRUITING NOW**
Interventions: Â Drug:Â Imiquimod; Â Biological:Â Pembrolizumab; Â Biological:Â Sotigalimab; Â Biological: Synthetic Tumor-Associated Peptide Vaccine Therapy
Sponsors:  M.D. Anderson Cancer Center;  National Cancer Institute (NCI)
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
